LC-NMR-MS in drug discovery

Drug Discovery Today

Volumn 8, Issue 14, 2003, Pages 624-631

  Corcoran, Olivia ^a   Spraul, Manfred ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b BRUKER BIOSPIN GMBH   (Germany)

Author keywords

Biotechnology; CryoFlowProbes; Discovery; Drug Discovery; LC NMR MS; LC SPE NMR; Metabolite identification; Natural products; NMR spectroscopy; Pharmaceutical Science; Reactive metabolites; Techniques Methods

Indexed keywords

NEW DRUG;

COMPUTER; COMPUTER PROGRAM; DRUG METABOLISM; DRUG STRUCTURE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; REVIEW; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION;

CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, LIQUID; COMPUTERS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; PHARMACEUTICAL PREPARATIONS;

EID: 0038012572     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(03)02749-1     Document Type: Review

References (39)

1. Watt A.T., et al. Metabolite identification in drug discovery. Curr. Opin. Drug Disc. Dev. 6:2003;57-65.
2. Alberts K. On-line LC-NMR and Related Techniques. 2002;John Wiley & Sons.
3. Holzgrabe U., et al. NMR Spectroscopy in Drug Development and Analysis. 1998;Wiley-VCH.
4. 1H NMR spectroscopic studies of the reactive α-1-O-acyl isomer formed during acyl migration of S-naproxen β-1-O-acyl glucuronide. Chem. Res. Toxicol. 14:2001;1363-1370.
5. Ruhl R., et al. Synthesis, high-performance liquid-chromatography-nuclear magnetic resonance characterization and pharmacokinetics in mice of CD271 glucuronide. J. Chromatogr. B Biomed. Appl. 757:2001;101-109.
6. Dear G.J., et al. Mass directed peak selection, an efficient method of drug metabolite identification using directly coupled liquid-chromatography-mass spectrometry-nuclear magnetic resonance spectroscopy. J. Chromatogr. B Biomed. Appl. 748:2000;281-293.
7. Lommen A., et al. Application of directly coupled HPLC-NMR-MS to the identification and confirmation of quercetin glycosides and phloretin glycosides in apple peel. Anal. Chem. 72:2000;1793-1797.
8. Spraul M., et al. Advancing sensitivity for LC-NMR-MS using a cryogenic probe: application to the metabolites of acetaminophen. Anal. Chem. 75:2003;1546-1551.
9. Cannell R.J.P., et al. Novel metabolites of warfarin produced by Beauveria bassiana and Streptomyces rimosus: a novel application of HPLC-NMR. Xenobiotica. 27:1997;147-157.
10. Tseng L.H., et al. Structure identification of aporphine alkaloids by on-line coupling of HPLC-NMR with loop storage. J. Chin. Chem. Soc. 47:2000;1231-1236.
11. Shockcor J.P., et al. Application of directly coupled LC-NMR-MS to the structural elucidation of metabolites of the HIV-1 reverse transcriptase inhibitor BW935U83. J. Chromatogr. B Biomed. Appl. 784:2000;269-279.
12. 13C]-4-trifluoromethoxyacetanilide in the rat: detection and identification of metabolites excreted in the urine by NMR and HPLC-NMR. J. Pharm. Biomed. Anal. 28:2002;875-885.
13. Dear G.J., et al. The potential of serially coupled alkyl-bonded silica monolithic columns for high resolution separations of pharmaceutical compounds in biological fluids. Chromatographia. 55:2002;177-184.
14. Sandvoss M., et al. Isolation and structural elucidation of steroid oligoglycosides from the starfish Asterias rubens by means of direct online LC-NMR-MS hyphenation and 1 and 2 dimensional NMR investigations. Eur. J. Org. Chem. 7:2000;1253-1262.
15. Li A.P. A review of the common properties of drugs with idiosyncratic hepatotoxicity and the 'multiple determinant hypothesis' for the manifestation of idiosyncratic drug toxicity. Chem. Biol. Interact. 142:2002;7-23.
16. Wolfender J.L., et al. Liquid chromatography coupled to mass spectrometry and nuclear magnetic resonance spectroscopy for the screening of plant constituents. J. Chromatogr. A. 794:1998;299-316.
17. Bobzin S.C., et al. Application of liquid chromatography-nuclear magnetic resonance spectroscopy to the identification of natural products. J. Chromatogr. B Biomed. Appl. 748:2000;259-267.
18. Wilson I.D., et al. High performance liquid chromatography coupled to nuclear magnetic resonance spectroscopy and mass spectrometry applied to plant products: identification of ecdysteroids from Silene Otides. Chromatographia. 49:1999;374-378.
19. 19F NMR spectroscopy for rapid screening of cell cultures for models of mammalian drug metabolism. Analyst. 126:2001;2103-2106.
20. Abel C.B.L., et al. Characterization of metabolites in intact Streptomyces citricolor culture supernatants using high resolution nuclear magnetic resonance spectroscopy and directly coupled high-pressure liquid chromatography-nuclear magnetic resonance spectroscopy. Anal. Biochem. 270:1999;220-230.
21. Chin J., et al. HPLC-NMR in combinatorial chemistry. J. Org. Chem. 63:1998;386-390.
22. Lindon J.C., et al. Separation and characterization of components of peptide libraries using on-flow coupled HPLC-NMR spectroscopy. Magn. Reson. Chem. 33:1995;863-875.
23. Mutlib A.E., et al. Application of hyphenated LC/NMR and LC/MS techniques in rapid identification of in vitro and in vivo metabolites of iloperidone. Drug Metab. Dispos. 23:1995;951-964.
24. 1H NMR spectroscopy for drug metabolism and detection and characterization: the identification of paracetamol metabolites in urine and bile. NMR Biomed. 7:1995;295-303.
25. Ehlhardt W.J., et al. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations. Drug Metab. Dispos. 26:1998;42-51.
26. Potts W., et al. Pharmacokinetic assessment of a mixture of compounds in the rat using simultaneous dosing and simultaneous LC/MS/MS quantitation. ISSX Proc. 8:1995;404.
27. Tarbit M.H., Berman J. High-throughput approaches for evaluating absorption, distribution, metabolism and excretion of lead compounds. Curr. Opin. Chem. Biol. 2:1998;411-416.
28. 19F NMR spectroscopy. Anal. Commun. 36:1999;259-261.
29. Zhang K.E., et al. Liquid-chromatography mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease. Drug Metab. Dispos. 29:2001;729-734.
30. Shockcor J.P., et al. Characterization of in vitro metabolites from human liver microsomes using directly coupled HPLC-NMR: application to a phenoxathiin monoamine oxidase-A inhibitor. Xenobiotica. 26:1996;41-48.
31. Corcoran O., et al. 750 MHz HPLC-NMR spectroscopic identification of rat microsomal metabolites of phenoxypyridines. J. Pharm. Biomed. Anal. 16:1997;481-489.
32. 1H NMR. Anal. Chem. 71:1999;315A-321A.
33. Pusecker K., et al. On-line coupling of capillary electro-chromatography, capillary electrophoresis, and capillary HPLC with nuclear magnetic resonance spectroscopy. Anal. Chem. 70:1998;3280-3285.
34. Gfrorer P., et al. Gradient elution capillary electrochromatography and hyphenation with nuclear magnetic resonance. Electrophoresis. 20:1999;3-8.
35. Corcoran O., et al. Advancing sensitivity for flow NMR spectroscopy: LC-SPE-NMR and capillary-scale LC-NMR. Am. Lab. 34:2002;18-21.
36. Kautz R.A., et al. Sample concentration and separation for nanoliter-volume NMR spectroscopy using capillary isotachophoresis. J. Am. Chem. Soc. 123:2001;3159-3160.
37. Wolters A.M., et al. Capillary isotachophoresis/NMR: extension to trace impurity analysis and improved instrumental coupling. Anal. Chem. 74:2002;2306-2313.
38. Sidelmann U.G., et al. Directly coupled 800 MHz HPLC-NMR spectroscopy of urine and its application to the identification of the major phase II metabolites of tolfenamic acid. Anal. Chem. 69:1997;607-612.
39. Styles P., et al. A high-resolution NMR probe in which the coil and preamplifier are cooled with liquid helium. J. Magn. Reson. 60:1984;397-404.